CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of early drug development software solutions, announced today it has signed a global partnership agreement with SAS, the leader in business analytics software and services. The partnering arrangement enables Instem to more cost effectively license its clients directly for SAS® technology embedded within its Provantis® preclinical software suite. This will streamline deployment processes and reduce costs for clients, especially for laboratories with smaller numbers of users.
